相关实验视频

Updated: May 14, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

案例341:下垂体后部可逆脑病症综合征与因特勒-β相关,在复发性多发性硬化症中

Nikolaos S Avramiotis¹, Matthias A Mutke², Matthias Mehling¹

¹Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Petersgraben 4, 4031 Basel, Switzerland.

|September 30, 2025

概括

本案例研究详细介绍了一名复发性多发性硬化症 (RMS) 患者在接受干扰素-β (INF-β) 治疗时出现视力模糊和血压升高. 调查显示高血压视网膜病变和活跃的RMS病变,促使抗高血压治疗.

科学领域:

神经学神经学
免疫学免疫学免疫学
眼科医生眼科眼科

背景情况:

一名36岁的男性有13年的复发性多发性硬化症 (RMS) 病史,接受了皮下干扰素-β (INF-β) 治疗.
该患者在一周的病史中出现了视力模糊,并发现血压明显升高 (214/122毫米升).
以前的MRI显示了新的小脑病变,暗示有活跃的RMS,没有神经缺陷.

研究的目的:

在接受INF-β治疗的RMS患者中调查视力模糊的原因.
评估患者的神经状况,心血管健康以及潜在的治疗副作用.
确定适合患者呈现症状和潜在疾病的治疗策略.

主要方法:

临床表现和病史审查.
身体检查,包括神经学和眼科评估 (眼镜检查).
实验室分析包括肝酶,尿液分析 (microalbuminuria),脂质概况,中枢神经液分析 (基克隆带,病原体和JC病毒的PCR).
大脑的磁共振成像 (MRI).

主要成果:

基底镜检查显示双边高血压视网膜病变;神经检查正常,除了斜视 (EDSS 1) 外.
实验室测试显示肝酶升高 (可能是由于INF-β),微专尿和高脂血症.
脑脊液分析对形带呈阳性,但对脑膜炎/脑炎病原体和JC病毒DNA呈阴性.
大脑MRI证实了新的小脑病变,并启动了用大红和安洛迪平的抗高血压治疗.

结论:

患者的症状归因于高血压视网膜病变和活性RMS病变的组合.
采用了等待和观察的方法,避免使用类固醇或抗菌药物治疗.
管理重点是控制高血压和监测RMS活动.

更多相关视频

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

相关概念视频

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Encephalitis l: Introduction

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...